Rbc capital further trims zynex (zyxi) target, investor lawsuit looms – hagens berman

San francisco, may 05, 2025 (globe newswire) -- zynex, inc. (nasdaq: zyxi), the denver-based medical technology firm, is facing a deepening vortex of financial, regulatory and legal challenges, with rbc capital markets reportedly further reducing its outlook on the company's stock. the company faces added pressure from a recently filed securities class action lawsuit, alleging the company made false and misleading statements regarding its revenue recognition practices and its relationship with tricare, a major payer now temporarily suspending payments.
ZYXI Ratings Summary
ZYXI Quant Ranking